93
Views
19
CrossRef citations to date
0
Altmetric
Review

Quantitation of target proteins and post-translational modifications in affinity-based proteomics approaches

Pages 421-428 | Published online: 09 Jan 2014

References

  • Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson RW. Investigating diversity in human plasma proteins. Proc. Natl Acad. Sci. USA102(31), 10852–10857 (2005).
  • Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson RW. Population proteomics: the concept, attributes, and potential for cancer biomarker research. Mol. Cell. Proteomics5(10), 1811–1818 (2006).
  • Kiernan UA, Nedelkov D, Niederkofler EE et al. Biomarker identification and validation with targeted cardiac population proteomics. Proceedings of the 53rd ASMS Conference on Mass Spectrometry and Allied Topics. San Antonio, TX, USA 5–9 June 2005.
  • Gygi SP, Rist B, Gerber SA et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol.17(10), 994–999 (1999).
  • Anderson NL, Anderson NG, Haines LR et al. Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA). J. Proteome Res.3(2), 235–244 (2004).
  • Kirkpatrick DS, Gerber SA, Gygi SP. The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications. Methods35(3), 265–273 (2005).
  • Chen X, Sun L, Yu Y, Xue Y, Yang P. Amino acid-coded tagging approaches in quantitative proteomics. Expert Rev. Proteomics4(1), 25–37 (2007).
  • Ong SE, Blagoev B, Kratchmarova I et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics1(5), 376–386 (2002).
  • Hutchens TW, Yip TT. New desorption strategies for the mass-spectrometric analysis of macromolecules. Rapid Commun. Mass Spectrom.7(7), 576–580 (1993).
  • Petricoin EF, Ardekani AM, Hitt BA et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet359(9306), 572–577 (2002).
  • Howard BA, Wang MZ, Campa MJ et al. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis. Proteomics3(9), 1720–1724 (2003).
  • Cho WC, Yip TT, Yip C et al. Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin. Cancer Res.10(1 Pt 1), 43–52 (2004).
  • Tolson J, Bogumil R, Brunst E et al. Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid α in renal cancer patients. Lab. Invest.84(7), 845–856 (2004).
  • Xiao Z, Adam BL, Cazares LH et al. Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease. Cancer Res.61(16), 6029–6033 (2001).
  • Nelson RW, Krone JR, Bieber AL, Williams P. Mass-spectrometric immunoassay. Anal. Chem.67(7), 1153–1158 (1995).
  • Brockman AH, Orlando R. Probe-immobilized affinity chromatography/mass spectrometry. Anal. Chem.67(24), 4581–4585 (1995).
  • Brockman AH, Orlando R. New immobilization chemistry for probe affinity mass spectrometry. Rapid Commun. Mass Spectrom.10(13), 1688–1692 (1996).
  • Yip TT, Van de Water J, Gershwin ME, Coppel RL, Hutchens TW. Cryptic antigenic determinants on the extracellular pyruvate dehydrogenase complex/mimeotope found in primary biliary cirrhosis. A probe by affinity mass spectrometry. J. Biol. Chem.271(51), 32825–32833 (1996).
  • Zhao Y, Muir TW, Kent SB et al. Mapping protein–protein interactions by affinity-directed mass spectrometry. Proc. Natl Acad. Sci. USA,93(9), 4020–4024 (1996).
  • Liang X, Lubman DM, Rossi DT, Nordblom GD, Barksdale CM. On-probe immunoaffinity extraction by matrix-assisted laser desorption/ionization mass spectrometry. Anal. Chem.70(3), 498–503 (1998).
  • Davies H, Lomas L, Austen B. Profiling of amyloid-β peptide variants using SELDI Protein Chip arrays. BioTechniques27(6), 1258–1261 (1999).
  • Liotta LA, Petricoin EF. Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. J. Clin. Invest.116(1), 26–30 (2006).
  • Jackson A, Hunter C, Thomas J et al. Enrichment of lower abundance peptides from human plasma using SISCAPA. Presented at: HUPO 5th Annual World Congress. Longbeach, CA, USA, 28 October–1 November 2006.
  • Wenzel T, Sparbier K, Shi G, Wolfgang P, Kostrzewa M. Pre-activated magnetic-particles for generating user-defined protein beads and their application in MALDI-TOF MS. Presented at: HUPO 5th Annual World Congress Longbeach, CA USA, 28 October–1 November 2006.
  • Niederkofler EE, Tubbs KA, Gruber K et al. Determination of β-2 microglobulin levels in plasma using a high-throughput mass spectrometric immunoassay system. Anal. Chem.73(14), 3294–3299 (2001).
  • Kiernan UA, Tubbs KA, Gruber K et al. High-throughput protein characterization using mass spectrometric immunoassay. Anal. Biochem.301(1), 49–56 (2002).
  • Nedelkov D, Tubbs KA, Niederkofler EE, Kiernan UA, Nelson RW. High-throughput comprehensive analysis of human plasma proteins: a step toward population proteomics. Anal. Chem.76(6), 1733–1737 (2004).
  • Nedelkov D. Population proteomics: addressing protein diversity in humans. Expert Rev. Proteomics2(3), 315–324 (2005).
  • Kiernan UA, Nedelkov D, Tubbs KA, Niederkofler EE, Nelson RW. Proteomic characterization of novel serum amyloid P component variants from human plasma and urine. Proteomics4(6), 1825–1829 (2004).
  • Niederkofler EE, Tubbs KA, Kiernan UA, Nedelkov D, Nelson RW. Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins. J. Lipid Res.44(3), 630–639 (2003).
  • Kiernan UA, Nedelkov D, Tubbs KA, Niederkofler EE, Nelson RW. Selected expression profiling of full-length proteins and their variants in human plasma. Clin. Proteomics J.1(1), 7–16 (2004).
  • Nelson RW, Nedelkov D, Tubbs KA, Kiernan UA. Quantitative mass spectrometric immunoassay of insulin like growth factor 1. J. Proteome Res.3(4), 851–855 (2004).
  • Kiernan UA, Tubbs KA, Nedelkov D, Niederkofler EE, Nelson RW. Comparative phenotypic analyses of human plasma and urinary retinol binding protein using mass spectrometric immunoassay. Biochem. Biophys. Res. Commun.297(2), 401–405 (2002).
  • Kiernan UA, Tubbs KA, Nedelkov D, Niederkofler EE, Nelson RW. Detection of novel truncated forms of human serum amyloid A protein in human plasma. FEBS Lett.537(1–3), 166–170 (2003).
  • Tubbs KA, Nedelkov D, Nelson RW. Detection and quantification of β-2-microglobulin using mass spectrometric immunoassay. Anal. Biochem.289(1), 26–35 (2001).
  • Kiernan UA, Addobbati R, Nedelkov D, Nelson RW. Quantitative multiplexed C-reactive protein mass spectrometric immunoassay. J. Proteome Res.5(7), 1682–1687 (2006).
  • Nelson RW, McLean MA, Hutchens TW. Quantitative-determination of proteins by matrix-assisted laser-desorption ionization time-of-flight mass-spectrometry. Anal. Chem.66(9), 1408–1415 (1994).

Patents

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.